CIK 0001855644 · <br>Emerging growth company
Zura Bio Ltd
Sign in to watch- Ticker
- ZURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 858-247-0520
- Business address
- 4225 EXECUTIVE SQUARE, SUITE 600, LA JOLLA, CA, 92037
- Former names
- JATT Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Nirula Ajay Director | Grant or award · Share Option (Right to Buy) | +51,000 | 51,000 | ||
| 2026-06-17 | Thiara Parvinder Director | Grant or award · Share Option (Right to Buy) | +51,000 | 51,000 | ||
| 2026-06-17 | Schoch Steven J Director | Grant or award · Share Option (Right to Buy) | +51,000 | 51,000 | ||
| 2026-06-17 | Eisner Mark Director | Grant or award · Share Option (Right to Buy) | +51,000 | 51,000 | ||
| 2026-06-17 | Becker Daniel J. Director | Grant or award · Share Option (Right to Buy) | +51,000 | 51,000 | ||
| 2026-06-17 | Jarrett Jennifer Director | Grant or award · Share Option (Right to Buy) | +51,000 | 51,000 | ||
| 2026-06-17 | Munshi Amit Director | Grant or award · Share Option (Right to Buy) | +51,000 | 51,000 | ||
| 2026-04-01 | Nistala Kiran See Remarks | Grant or award · Employee Share Option (Right to Buy) | +340,900 | 340,900 | ||
| 2026-04-01 | Hyllengren Eric J Chief Financial Officer | Grant or award · Employee Share Option (Right to Buy) | +340,900 | 340,900 | ||
| 2026-04-01 | Whale Gary Chief Technology Officer | Grant or award · Employee Share Option (Right to Buy) | +263,000 | 263,000 | ||
| 2026-04-01 | Davis Kim Chief Legal Officer | Grant or award · Employee Share Option (Right to Buy) | +425,700 | 425,700 | ||
| 2026-04-01 | Kulkarni Sandeep Chidambar Chief Executive Officer | Grant or award · Employee Share Option (Right to Buy) | +894,000 | 894,000 | ||
| 2026-02-26 | AI Biotechnology LLC 10% owner | Purchase | +2,000,000 | $6.25 | $12.5M | 6,552,725 |
| 2026-02-21 | Nirula Ajay Director | Grant or award · Share Option (Right to Buy) | +37,812 | 37,812 | ||
| 2026-02-21 | Eisner Mark Director | Grant or award · Share Option (Right to Buy) | +37,812 | 37,812 | ||
| 2026-01-23 | Thiara Parvinder Director | Grant or award · Share Option (Right to Buy) | +38,823 | 38,823 | ||
| 2026-01-21 | Kulkarni Sandeep Chidambar Chief Executive Officer | Grant or award · Employee Share Option (Right to Buy) | +2,934,107 | 2,934,107 | ||
| 2025-07-15 | Hyllengren Eric J Chief Financial Officer | Grant or award · Employee Share Option (Right to Buy) | +672,000 | 672,000 | ||
| 2025-05-29 | Becker Daniel J. Director | Grant or award · Share Option (Right to Buy) | +51,000 | 51,000 | ||
| 2025-05-21 | Ploos van Amstel Arnout Director | Grant or award · Share Option (Right to Buy) | +51,000 | 51,000 |
Page 1 of 5 · 85 trades